CheckMyRecalls

Oxoid Limited recalls Lev5

Published
12 Feb 2025
Units affected
1406 units
Agency
FDA
Country
United States

The hazard

Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797

Brand / company
Oxoid Limited
Codes / lots
Lot # 6142394/UDI: 5032384079629
Distribution
US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.